1. Home
  2. VERA vs SXI Comparison

VERA vs SXI Comparison

Compare VERA & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • SXI
  • Stock Information
  • Founded
  • VERA 2016
  • SXI 1955
  • Country
  • VERA United States
  • SXI United States
  • Employees
  • VERA N/A
  • SXI N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • VERA Health Care
  • SXI Industrials
  • Exchange
  • VERA Nasdaq
  • SXI Nasdaq
  • Market Cap
  • VERA 2.0B
  • SXI 2.3B
  • IPO Year
  • VERA 2021
  • SXI N/A
  • Fundamental
  • Price
  • VERA $23.20
  • SXI $158.74
  • Analyst Decision
  • VERA Buy
  • SXI Strong Buy
  • Analyst Count
  • VERA 8
  • SXI 3
  • Target Price
  • VERA $64.63
  • SXI $223.33
  • AVG Volume (30 Days)
  • VERA 1.3M
  • SXI 150.9K
  • Earning Date
  • VERA 08-07-2025
  • SXI 07-31-2025
  • Dividend Yield
  • VERA N/A
  • SXI 0.81%
  • EPS Growth
  • VERA N/A
  • SXI N/A
  • EPS
  • VERA N/A
  • SXI 5.04
  • Revenue
  • VERA N/A
  • SXI $748,252,000.00
  • Revenue This Year
  • VERA N/A
  • SXI $9.67
  • Revenue Next Year
  • VERA N/A
  • SXI $12.91
  • P/E Ratio
  • VERA N/A
  • SXI $31.43
  • Revenue Growth
  • VERA N/A
  • SXI 2.67
  • 52 Week Low
  • VERA $18.53
  • SXI $128.85
  • 52 Week High
  • VERA $51.61
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • VERA 49.75
  • SXI 53.07
  • Support Level
  • VERA $22.57
  • SXI $160.03
  • Resistance Level
  • VERA $24.58
  • SXI $169.98
  • Average True Range (ATR)
  • VERA 1.13
  • SXI 4.28
  • MACD
  • VERA 0.06
  • SXI -0.20
  • Stochastic Oscillator
  • VERA 38.05
  • SXI 46.04

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.

Share on Social Networks: